Exchange: OTC·Updated 03:59 PM EDT

NWBONorthwest Biotherapeutics Inc

$0.1944
$0.0044
(2.32%)
Today
EarningsAug 13
Mkt Cap$319.47M
Vol1.36M

About

Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient’s own immune system to attack their cancer. The company was founded by Alton L. Boynton on March 18, 1996 and is headquartered in Bethesda, MD.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
25

Frequently Asked Questions

What is Market Cap of Northwest Biotherapeutics Inc?
What is the 52-week high for Northwest Biotherapeutics Inc?
What is the 52-week low for Northwest Biotherapeutics Inc?
What is Northwest Biotherapeutics Inc stock price today?
What was Northwest Biotherapeutics Inc stock price yesterday?
What is the PE ratio of Northwest Biotherapeutics Inc?
What is the Price-to-Book ratio of Northwest Biotherapeutics Inc?
What is the 50-day moving average of Northwest Biotherapeutics Inc?
How many employees does Northwest Biotherapeutics Inc have?

Latest NWBO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.